Venturi Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Buy
8,239
+2,032
+33% +$110K 0.01% 465
2026
Q1
$389K Sell
6,207
-2,835
-31% -$227K 0.02% 410
2025
Q4
$862K Buy
9,042
+7
+0.1% +$686 0.04% 222
2025
Q3
$882K Buy
9,035
+169
+2% +$17.5K 0.04% 213
2025
Q2
$952K Buy
8,866
+654
+8% +$66.2K 0.05% 209
2025
Q1
$828K Buy
8,212
+592
+8% +$59.6K 0.04% 233
2024
Q4
$681K Buy
7,620
+5,821
+324% +$512K 0.03% 270
2024
Q3
$151K Buy
1,799
+692
+63% +$54.5K 0.01% 479
2024
Q2
$85.3K Buy
1,107
+624
+129% +$45.7K 0.01% 538
2024
Q1
$33.1K Sell
483
-103
-18% -$6.62K ﹤0.01% 598
2023
Q4
$33.9K Buy
586
+215
+58% +$11.5K ﹤0.01% 569
2023
Q3
$19.6K Buy
371
+326
+724% +$17.1K ﹤0.01% 629
2023
Q2
$2.44K Buy
+45
New +$2.35K ﹤0.01% 885

Other funds holding BSX

Venturi Wealth Management's BSX Position: Q2 2026 in Review

Venturi Wealth Management increased its Boston Scientific (BSX) stake by 33% in Q2 2026, buying an estimated $110K and bringing the position to 8,239 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #465.

Venturi Wealth Management first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $952K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Venturi Wealth Management held 8,239 shares of Boston Scientific worth $352K as of Q2 2026.
  • Venturi Wealth Management bought 2,032 Boston Scientific shares in Q2 2026, an estimated $110K.
  • Boston Scientific made up 0.01% of Venturi Wealth Management's portfolio in Q2 2026, its #465 holding.
  • Venturi Wealth Management first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • Venturi Wealth Management's Boston Scientific position peaked at $952K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.